The Oxford University spinout plans to use the investment to fuel its structural mass spectrometry to identify new medicines.
We publish news of technology innovations, investment opportunities, together with updates from spin-out & start-up companies and licensees
The University of Oxford spinout also inks clinical paper in Lancet Psychiatry, appoints CEO and sets up Oxford HQ and London development hub.
Brainomix builds on partnership with Boehringer Ingelheim for AI-assisted fast treatment of stroke victims in latest venture round.
Woodford Investment Management leads round into OxSyBio, the second Oxford University spinout from Oxford Nanopore founder Hagan Bayley
The Oxford University spinout will enable ‘display anywhere’ applications.